Elevated expression of IGFBP4 can lead to positive disease-free survival and OS in breast carcinoma [43], while IGFBP4 has a tumor-promoting effect on renal cell carcinoma by activating the Wnt/β-catenin signaling pathway [44]. Here, IGFBP4 is linked to renal cell carcinoma.